Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients

Not yet recruitingOBSERVATIONAL
Enrollment

1,185

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Stroke AcuteEncephalitisNon-traumatic Brain Injury
Trial Locations (19)

100053

Beijing Hui People's Hospital, Beijing

Xuanwu Hospital, Capital Medical University, Beijing

100069

You'anmen Hospital, Beijing

100700

The Ninth Medical Center of Chinese PLA General Hospital, Beijing

130021

The First Hospital of Jilin University, Jilin

215004

The Second Affiliated Hospital of Suzhou University, Suzhou

250012

Qilu Hospital of Shandong University, Jinan

250031

The 960th Hospital of Joint Logistics Support Force of Chinese PLA, Jinan

252000

Liaocheng People's Hospital, Liaocheng

550002

Guizhou Provincial People's Hospital, Guiyang

563003

Affiliated Hospital of Zunyi Medical University, Zunyi

650032

The First People's Hospital of Yunnan Province, Kunming

730050

The 940th Hospital of Joint Logistics Support Force of Chinese PLA, Lanzhou

750004

General Hospital of Ningxia Medical University, Yinchuan

063000

Tangshan People's Hospital, Tangshan

050031

The First Hospital of Hebei Medical University, Shijiazhuang

010017

Inner Mongolia Autonomous Region People's Hospital, Hohhot

024000

Chifeng Municipal Hospital, Chifeng

030001

The Second Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Yan Zhang

OTHER

NCT06849011 - Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients | Biotech Hunter | Biotech Hunter